Evidence map›Paper›PMID 35992680›Full record

ArticleFrontiers in microbiology2022

Cell-free supernatant of

Huanlan Zhao, Kui Liu, Yezhen Fan, Jiacan Cao, Huanghuan Li, Wu Song, Yongsheng Liu, Min Miao

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
7.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Characterization and Biocontrol Potential ofJournal of fungi (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Cyclic lipopeptides fromFrontiers in microbiology · 2026
    Article
  7. Frontiers in plant science · 2026
    Article
  8. Article
  9. Article
  10. Journal of fungi (Basel, Switzerland) · 2025
    Article
  11. Article
  12. Article
  13. Antagonistic StrainInternational journal of molecular sciences · 2024
    Article
  14. Counteracting Grey Mould (Microorganisms · 2024
    Article
  15. Article
  16. Identification of theFrontiers in microbiology · 2024
    Article
  17. Article
  18. Antagonistic properties ofFrontiers in microbiology · 2024
    Article
  19. Anti-inflammatory effect ofApplied and environmental microbiology · 2023
    Article
  20. Cell-Free Supernatant ofJournal of fungi (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Huanlan ZhaoSchool of Food and Biological Engineering, Hefei University of Technology, Hefei, China.
Kui LiuSchool of Food and Biological Engineering, Hefei University of Technology, Hefei, China.
Yezhen FanSchool of Food and Biological Engineering, Hefei University of Technology, Hefei, China.
Jiacan CaoSchool of Food and Biological Engineering, Hefei University of Technology, Hefei, China.
Huanghuan LiSchool of Biological Science and Engineering, North Minzu University, Yinchuan, China.
Wu SongSchool of Food and Biological Engineering, Hefei University of Technology, Hefei, China.
Yongsheng LiuMinistry of Education Key Laboratory for Bio-Resource and Eco-Environment, State Key Laboratory of Hydraulics and Mountain River Engineering, College of Life Science, Sichuan University, Chengdu, China.
Min MiaoSchool of Food and Biological Engineering, Hefei University of Technology, Hefei, China.
Hefei University of Technology · CNAnhui Agricultural University · CNInstitute of Botany · CNJiangnan University · CNNorth Minzu University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As a notorious pathogenic fungus,

Indexed as

Bacillus velezensisBotrytis cinereacell-free supernatantdamage of cell membranereactive oxygen species

Identifiers

PMID35992680
PMCPMC9389153
OpenAlexW4289943354

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.